MedPath

Investigation on Relation Between Serum Magnesium Level and Severity and Frequens of Attacks of Migraine Headache

Phase 3
Conditions
Migraine.
Migraine
Registration Number
IRCT2014091617945N2
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

age 18-65 years; Moderate to severe pain for 4-72 hours or more.
exclusion criteria: Fever or evidence of infection; Headaches; Pregnancy; Diabetes; Blood pressure; Ischemic heart disease and kidney disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum Magnesium levels. Timepoint: During the visit, a visit next month, the first two months. Method of measurement: laboratory.;Frequency of migraine headaches. Timepoint: During the visit, a visit next month, the first two months. Method of measurement: standard check list.;Severity of migraine headaches. Timepoint: During the visit, a visit next month, the first two months. Method of measurement: standard check list.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath